Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Carnamedica AB
AB
Active
Org 5591558647
Södra Hamngatan 5
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2018
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 2,3M
+11% vs 2024
EBITDA margin
2.8%
+117% vs 2024
Equity ratio
24.9%
Financial strength
Net profit 2025
SEK 36K
+116% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 2,3M
+11%
EBITDA
SEK 62K
+117%
Net profit
SEK 36K
+116%
Total assets
SEK 713K
+19%
Equity
SEK 178K
+26%
Employees
0
—
Company information
Legal name
Carnamedica AB
Org number
5591558647
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16 april 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Försäljning av perfusions och preservationslösningar, medicinsk tekniska produkter och läkemedel.
Contact
Address
Södra Hamngatan 5
Email
marie.sverkersdotter@carnamedica.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
1M
2021
1M
2022
1M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
634
823
1 191
2 046
2 269
Staff expenses
—
—
−11
−112
−180
EBITDA
31
86
29
29
62
Depreciation & amort.
−14
−9
−7
−5
−4
EBIT
17
77
22
23
58
Net financials
—
—
−0
−0
−3
Profit before tax
17
77
22
23
55
Tax
−4
−60
−5
−6
−19
Net profit
13
17
17
17
36
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
290
411
631
597
713
Equity
91
108
125
141
178
Long-term debt
0
0
—
—
—
Short-term debt
199
304
507
456
535
Total debt
199
304
507
456
535
Financial ratios
5-year trend
EBITDA margin
2.8%
This company
15.8%
Market median
-82% vs market
2021
2025
Equity ratio
24.9%
This company
38.2%
Market median
-35% vs market
2021
2025
Return on equity
20.4%
This company
18.4%
Market median
+11% vs market
2021
2025
Net profit margin
1.6%
This company
8.1%
Market median
-80% vs market
2021
2025
Asset turnover
3.18×
This company
1.12×
Market median
+184% vs market
2021
2025
Debt / equity
3.02×
This company
0.62×
Market median
-387% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AM
Anna Marie Sverkersdotter
Board of Directors
2022
MM
Monika Maria Tausis
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Carnamedica AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anna Marie Sverkersdotter
Board of Directors
0 companies
Monika Maria Tausis
Deputy Board Member
0 companies